Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GGZ vs GRX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GRX Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 3–1 Matrix Metrics)

GRX Overall Winner 6-Pillar Tally: GGZ 0 – 1 GRX (5 Tie) Matrix Metrics: GGZ 1 – 3 GRX

As of Nov 16, 2026, The Gabelli Healthcare & Wellness Trust (GRX) is the stronger overall head-to-head candidate over The Gabelli Global Small and Mid Cap Value Trust (GGZ) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). GGZ carries a Unified Composite Score of 48.9/100 (HOLD) at $14.99 (N/M Forward P/E, N/A operating margin), whereas GRX carries 41.3/100 (SELL) at $10.58 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While GGZ currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. GRX 41.3/100 SELL), GRX captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: GGZ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile GRX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 70.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GGZ vs GRX
GGZ NYSE
The Gabelli Global Small and Mid Cap Value Trust
Institutional Equity
$14.99
-1.54% 1D
Market Cap $114.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.71β · 18% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 49.0 Fund 52.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -3.8%) with fading momentum, RSI 45
RSI-14: 44.8 · SMA20: $15.07 · SMA50: $15.32
GRX NYSE Head-to-Head Winner
The Gabelli Healthcare & Wellness Trust
Institutional Equity
$10.58
+1.63% 1D
Market Cap $142.9M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.14β · 14% Vol
Unified Composite Score
41.3 / 100 SELL
Tech 30.0 Fund 43.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 70
RSI-14: 70.2 · SMA20: $10.24 · SMA50: $9.91

6-Pillar Scorecard Institutional Category Breakdown (GGZ 0 – 1 GRX)

Columns: Metric · GGZ · GRX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale GRX
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $114.2M $142.9M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GGZ (1) vs GRX (3)
Institutional Metric GGZ GRX Criterion Row Edge
Market Capitalization
Scale
$114.2M $142.9M Larger Scale GRX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
44% ($13–$17) 91% ($9–$11) Stronger Trend GRX
Beta / 30D Volatility
Risk Regime
0.71β · 18% Vol 0.14β · 14% Vol Lower Realized Risk GRX
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 41.3 / 100 (SELL) Higher Composite GGZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GRX +4.93 pp
GGZ: -0.07% · GRX: +4.86%
3M Horizon GRX +17.95 pp
GGZ: -11.3% · GRX: +6.65%
6M Horizon GRX +21.18 pp
GGZ: -2.57% · GRX: +18.61%
1Y Horizon GRX +5.1 pp
GGZ: +6.39% · GRX: +11.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GGZ vs GRX. Trailing 12-month operating profitability (GGZ N/A vs GRX N/A) and valuation multiples (GGZ N/M vs GRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GGZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
GRX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GGZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GGZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GRX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GGZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $114.2M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GRX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $142.9M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GGZ vs GRX Key Questions & Quantitative Answers

As of Nov 16, 2026, The Gabelli Healthcare & Wellness Trust (GRX) is the stronger overall head-to-head candidate over The Gabelli Global Small and Mid Cap Value Trust (GGZ) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). GGZ carries a Unified Composite Score of 48.9/100 (HOLD) at $14.99 (N/M Forward P/E, N/A operating margin), whereas GRX carries 41.3/100 (SELL) at $10.58 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While GGZ currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. GRX 41.3/100 SELL), GRX captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: GGZ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile GRX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 70.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GRX leads the Growth & Scale pillar: GGZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with GRX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, GGZ generates N/A in USD-normalized revenue versus N/A for GRX. In operating R&D and SG&A reinvestment, GGZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GRX.

GGZ and GRX trade at balanced relative valuation multiples. GGZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GRX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GGZ (N/A ROE) versus GRX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, GGZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.71β · 18% Vol realized risk). By comparison, GRX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 14% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

The Gabelli Global Small and Mid Cap Value Trust (GGZ) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.